Data presented at the San Antonio Breast Cancer Symposium also showed that 72% of evaluable patients saw an increase in CelTIL, the study's primary ...
News
- Oncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q4 2020 Results - Earnings Call Transcript
- Texas Biomed President Says It's Too Soon To Lift Pandemic Restrictions
Texas Biomed — a San Antonio research institute — played a key role in the development of the antibody treatment that former President Donald ...
- Edited Transcript of ONC.TO earnings conference call or presentation 5-Mar-21 1:30pm GMT
Q4 2020 Oncolytics Biotech Inc Earnings Call Calgary Mar 5, 2021 ... recent AWARE-1 update at the 2020 San Antonio Breast Cancer Symposium.
- Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational ...
AWARE-1 data presented at the 2020 San Antonio Breast Cancer Symposium (SABCS) showed that systemic pelareorep treatment increased tumor ...
- NGM Biopharmaceuticals: Q4 Earnings Snapshot
The biotechnology company posted revenue of $19.8 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected ...